Speakers
-
Andrea Ablasser
EPFL, Switzerland -
Patrick Aloy
IRB Barcelona, Spain -
Brenda Andrews
University of Toronto, Canada -
Yimon Aye
EPFL, Switzerland -
Gonçalo Bernardes
University of Cambridge, UK and iMM Lisboa, Portugal -
Michael Boutros
German Cancer Research Center, Germany -
Paul Brennan
University of Oxford, UK -
Kristin Brown
GlaxoSmithKline, UK -
Neil Carragher
The University of Edinburgh, UK -
Adrian Carter
Boehringer Ingelheim, Germany -
Alessio Ciulli
University of Dundee, UK -
Christine Donahue
GlaxoSmithKline, USA -
Anne-Claude Gavin
University of Geneva, Switzerland -
Kai Johnsson
Max Planck Institute for Medical Research, Germany -
Stefan Knapp
Goethe University Frankfurt, Germany -
Anke Müller-Fahrnow
Bayer AG, Germany -
Tudor Oprea
University of New Mexico, USA -
Maurizio Pellecchia
University of California, Riverside, USA -
Alleyn Plowright
Sanofi, Germany -
Katrin Rittinger
The Francis Crick Institute, UK -
Heiko Runz
Biogen, USA -
Eytan Ruppin
National Cancer Institute, USA -
Berend Snijder
ETH Zürich, Switzerland -
Giulio Superti-Furga
Center for Molecular Medicine, Austria -
Herbert Waldmann
Max Planck Institute of Molecular Physiology, Germany -
Paul Workman
CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK -
Judith Zaugg
EMBL Heidelberg, Germany -
Michael Zimmermann
EMBL Heidelberg, Germany
Scientific Organisers
-
Patrick Aloy
IRB Barcelona, Spain -
Adrian Carter
Boehringer Ingelheim, Germany -
Gerard Drewes
Cellzome, a GlaxoSmithKline company, Germany -
Anne-Claude Gavin
University of Geneva, Switzerland -
Stefan Knapp
Goethe University Frankfurt, Germany -
Anke Müller-Fahrnow
Bayer AG, Germany
Conference Organisers
-
Jonathan Rothblatt
EMBL Heidelberg, Germany -
Elisabeth Wintersteller
EMBL Heidelberg, Germany